HiberCell
PrivateLast Round
Series B
May 19, 2021
Total Funding Raised
$158.15M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
HiberCell is a biotechnology company that develops therapeutic agents targeting adaptive stress pathways and immune modulation to combat cancer treatment resistance, relapse, and metastasis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HiberCell Comparables
Compare HiberCell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oniria Therapeutics | 81% | |
| Bantam Pharmaceutical | 78% | |
| NMS Group | 74% | |
HiberCell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 19, 2021 | ||||
| Debt | May 19, 2021 | ||||
| Series A | Feb 7, 2019 |
HiberCell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Magnetic Ventures | Series B |
| New York City Economic Development Corporation | Series A |
| Hercules Capital | Debt, Series B |
| Hillhouse Investment | Series A |
| ARCH Venture Partners | Series B, Series A |
| Magnetic Ventures | Series B |
| Trinitas Capital Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 199% MoM, reaching 1.6K.
- May 19, 2021
$30M debt round led by Hercules Capital.
HiberCell Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HiberCell's valuation, stock price, and market status.